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ABSTRACT  
Background: High intensity interval training (HIIT) confers superior cardiovascular health 
benefits to moderate intensity continuous training (MICT) in adults and may be efficacious 
for improving diminished cardiac function in obese children. The aim of this study was to 
compare the effects of HIIT, MICT and nutrition advice interventions on resting left 
ventricular (LV) peak systolic tissue velocity (S’) in obese children.  
 
Methods: Ninety-nine obese children were randomised into one of three 12-week 
interventions, 1) HIIT [n=33, 4 x 4 min bouts at 85–95% maximum heart rate (HRmax), 3 
times/week] and nutrition advice, 2) MICT [n=32, 44 mins at 60–70% HRmax, 3 times/week] 
and nutrition advice, and 3) nutrition advice only (nutrition) [n=34].  
 
Results: Twelve weeks of HIIT and MICT were equally efficacious, but superior to nutrition, 
for normalising resting LV S’ in children with obesity (estimated mean difference 1.0cm/s, 
95% confidence interval 0.5 to 1.6cm/s, P<0.001; estimated mean difference 0.7cm/s, 95% 
confidence interval 0.2 to 1.3cm/s, P=0.010, respectively).  
 
Conclusions: Twelve weeks of HIIT and MICT were superior to nutrition advice only for 
improving resting LV systolic function in obese children.  
 
Clinical Trial Registration: ClinicalTrials.gov Identifier: NCT01991106  
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ABBREVIATIONS 
a’ Peak late diastolic tissue velocity 
BMI 
CRF 
CV 
CVD 
Body mass index 
Cardiorespiratory fitness 
Cardiovascular 
Cardiovascular disease 
e’ 
EF 
Peak early diastolic tissue velocity 
Ejection fraction 
FMD Flow mediated dilation 
GLS Global longitudinal strain 
HIIT High intensity interval training 
HRmax Maximum heart rate 
LMM Linear mixed model 
LV Left ventricle 
MICT Moderate intensity continuous training 
NTNU Norwegian University of Science and Technology 
REML Restricted maximum likelihood 
RV Right ventricle 
S’ Peak systolic tissue velocity 
SD Standard deviation 
SR Strain rate 
UQ The University of Queensland 
V̇maxLVOT Maximal velocity in left ventricular outflow tract 
V̇O2peak Peak oxygen uptake 
W Watts 
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Pediatric obesity is associated with increased all-cause and cardiovascular (CV) 
mortality 
1,2
, independent of adult adiposity 
3
. Resting echocardiographic studies show 
significant systolic and diastolic alterations in cardiac function among children with obesity 
including lower left ventricular (LV) peak systolic tissue velocity (S’), global longitudinal 
strain (GLS) and strain rate (SR) when compared to their healthy-weight counterparts 
4-9
. 
Alterations in cardiac function may be unmasked earlier and be more pronounced during 
peak exercise 
5
 which highlights the importance of maximal exercise testing in this 
population 
10
. Prognostically, S’ is a strong and independent predictor of event-free survival 
in adults with acute coronary syndrome, is robust and can be easily obtained during rest and 
exercise 
11
. Subclinical impairments in cardiac function may be accompanied by endothelial 
dysfunction as assessed by brachial artery flow-mediated dilation 
12-14
, supporting the notion 
that children with obesity are at increased risk for development of CV disease (CVD) when 
compared to children with a healthy weight.  
While regular exercise may normalise subclinical reductions in CV function observed 
in obese children 
5,9,15
, there is often poor adherence to current physical activity guidelines 
among all children
16
. High intensity interval training (HIIT) is highly efficacious for 
ameliorating CV and cardiometabolic outcomes in adults with chronic disease 
17-22
 and 
children with obesity 
23
 compared to moderate intensity continuous training (MICT) or 
standard care. However, it is currently unknown whether HIIT can normalise subclinical 
reductions in CV function among obese children.  
Therefore, the aim of this investigation was to compare the effect of twelve weeks of 
HIIT, MICT and nutrition advice on resting systolic cardiac function (LV S’) in children with 
obesity. We hypothesised that HIIT would be more efficacious than MICT or nutrition advice 
only for improving systolic cardiac function (LV S’) at rest. In addition to the primary 
outcome, we aimed to compare the effect of the three interventions on LV and right 
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ventricular (RV) resting diastolic cardiac function (tissue Doppler velocities), GLS and SR 
during rest, peak exercise and recovery. 
METHODS 
Ninety-nine children with obesity, aged 7-16 years old (BMI ≥ percentile curves that 
pass through 30kg/m
2
 at age 18) 
24,25
 were recruited into a multicenter randomised controlled 
trial (Clinicaltrials.gov NCT01991106) at The University of Queensland (UQ), Brisbane, 
Australia and The Norwegian University of Science and Technology (NTNU), Trondheim, 
Norway between March 2012 and February 2017. In the same time period, 100 healthy-
weight children, aged 7-16 years old (BMI percentile curves that pass through 18kg/m
2 – 
25kg/m
2
 at age 18) 
24,25
 were assessed for comparative purposes but did not partake in the 
intervention. Parents or legal guardians of participants approved consent while participants 
provided written assent prior to participation. Participants were excluded if they presented 
with any of the following: hypertension, history of evidence of cardiac abnormalities, 
diabetes, smoking, or orthopaedic/neurological limitations that impacted their ability to 
exercise. Participants were not offered incentives for participating in the trial. Following 
baseline assessments, participants were randomly assigned 1:1:1 between three interventions 
and were stratified by age and sex. Allocation was performed by a web-based randomisation 
system developed and administered by Unit of Applied Clinical Research, The Faculty of 
Medicine and Health Sciences, NTNU, Norway and was fully concealed until the 
intervention was assigned. Detailed ethical approval, eligibility criteria, recruitment 
processes, randomisation procedures and study outcomes are outlined in the protocol 
26
.  
Participants were assessed for the following outcomes, (1) cardiac function and 
structure, (2) vascular function, and (3) cardiorespiratory fitness (CRF), in research 
laboratories at NTNU and UQ, and in hospital outpatient settings (St. Olav’s Hospital, 
Trondheim and the Wesley Hospital, Brisbane) at baseline and following the 12-week 
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intervention. Identical equipment and methodologies were used for each individual at each 
assessment. However, there were methodological differences between study centers for 
assessment of vascular function, which have been outlined in Supplemental Methods.  
Resting Echocardiography 
A full resting echocardiogram was conducted with a Vivid 7/E9/E95 ultrasound 
machine (GE Vingmed Ultrasound, Horten, Norway) using a phased-array transducer (GE 
M3S/M4S, 1.5 – 4 MHz). Three cine loops from the three standard apical planes (four-
chamber, two-chamber and five-chamber), and the parasternal long axis were recorded in 
grey scale harmonic mode and tissue Doppler mode simultaneously. LV and RV systolic and 
diastolic  function was assessed through standard Doppler echocardiographic indices 
(Supplemental Methods). Myocardial deformation analysis (speckle tracking 
echocardiography) was used to determined LV and right RV GLS and SR and is detailed in 
Supplemental Methods.  
Exercise Stress Echocardiography 
Following the resting echocardiogram, individuals exercised on a stationary cycle ergometer 
and apical 4-chamber and 2-chamber images in standard B-mode and B-mode with colour 
tissue Doppler were acquired in an upright, seated position during peak exercise for 
quantification of LV S’, e’ and A’ (Supplemental Methods). The cycling protocol started at 
an intensity of 25W and participants were subjected to 25W increments every three minutes 
until they attained their maximum heart rate or were no longer able to maintain a constant 
cadence. Apical 4-chamber and 2-chamber images in B-mode with colour tissue Doppler 
were acquired following e’-A’ separation for quantification of S’, e’ and A’ during recovery. 
Time to e’-A’ separation was also recorded.  
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EchoPAC (Version 112, GE Medical Systems, Milwaukee, WI, USA) was used for 
all echocardiographic analysis by a trained investigator and cardiologist who were blinded to 
the group allocation of the participants. 
Vascular Function  
Endothelial function of the brachial artery was measured via flow mediated dilation 
(FMD) using high-resolution vascular ultrasound (12–14MHz ultrasound- Doppler probe, 
Vivid 7 system/Vivid I system; GE Vingmed Ultrasound AS, Horten, Norway) in accordance 
with current methodological guidelines 
27
 and is further outlined in Supplemental Methods.  
Cardiorespiratory Fitness 
Participants completed a treadmill ramp protocol with respiratory gas analysis 
(Metamax 3B, Cortex Biophysik GmbH, Leipzig, Germany or Jaeger Oxycon Pro, 
CareFusion, Hoechberg, Germany) and a facemask system (Hans Rudolph, KS, USA) 
(Supplemental Methods). V̇O2peak was calculated as the average of the two highest 30-second 
values attained. 
Interventions 
Obese children were randomised into one of three groups (HIIT, MICT or nutrition 
alone) and all interventions were conducted continuously. The exercise interventions (HIIT 
and MICT) were designed to be isocaloric and required participants to train three times per 
week for 12 weeks. A minimum of two sessions were supervised by an exercise physiologist 
each week, while the third session could be unsupervised. Exercise protocols have been 
outlined in Figure 1 and are detailed in the study protocol 
26
. All groups received between 
four and six 20–30 minute nutrition consultations with a dietitian. Individual nutrition 
sessions were location-specific and were based on current Norwegian 
28
 and Australian 
29
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eating guidelines, specifically focusing on healthy food choices, portion sizes and regular 
meal times. 
Statistical Analysis   
For calculation of sample size, the clinically meaningful difference in peak systolic 
tissue velocity was set to 1cm/s with a standard deviation of 0.9cm/s 
11
 (power=0.80, 
alpha=0.05) and after accounting for 15% dropout, 105 participants were required to enter the 
randomised controlled trial. The sample size calculation is further detailed in the study 
protocol 
26
.  
Data are presented as mean (SD) if continuous and normally distributed, and medians 
(interquartile ranges) or counts (percentages) if non-normally distributed or categorical. A 
linear regression was used to estimate differences between obese and healthy-weight children 
at baseline, accounting for age, sex and center. Differences between the interventions were 
analysed using linear mixed models (LMMs), adjusting for age, sex and center, and allowing 
for a heterogeneous residual variance between centers. A subject-specific random intercept 
was used to account for within-participant correlations. The baseline means were restricted to 
be equal for all three interventions as participants were randomly allocated to a group. 
Likelihood ratio tests were used to determine overall effects and the final model was fitted 
using restricted maximum likelihood (REML). Between-group pairwise comparisons were 
carried out using Wald tests. Normality of raw data and residuals from the LMMs or linear 
regressions were assessed through visual examination of normal quantile-quantile plots and 
histograms and results from the Shapiro-Wilk test or Anderson-Darling test. Where outcomes 
of interest were transformed to satisfy model assumptions, the model parameter estimates are 
presented in the natural logarithmic (ln) transformed scale. 
An intention-to-treat (HIIT=33; MICT=32; nutrition=34) and per protocol analysis 
(HIIT=17; MICT=24; nutrition=21) was conducted for the LMM. All available data were 
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included in the intention-to-treat analysis, since the method of estimation for the LMM 
handles missing data. We assumed that data were missing at random, in which case the 
method produces unbiased estimates. For the per protocol analysis, participants were required 
to complete ≥80% of the exercise and/or nutrition sessions. Trial completion was calculated 
as (total number of sessions attended/total number of sessions available) x 100. SPSS 
Statistics (Version 24.0, IBM, Armonk, NY, USA) and the R Statistical Package (RStudio 
Team, Boston, MA, USA) were used to conduct statistical analyses. P values <0.05 were 
considered statistically significant. As there was only one primary outcome and the results of 
secondary outcomes were exploratory and interpreted as hypothesis generating, no formal 
adjustment for multiple testing was included.  
RESULTS 
A CONSORT diagram (Figure 2) summarises participant flow through each stage of 
the trial and outlines reasons for participant drop out. All available data were included in the 
intention-to-treat analysis and have been presented in a tabular format. Out of 99 participants 
who were randomised (NTNU = 68; UQ = 31), 62 participants (63%) successfully completed 
the trial and were included in per protocol analyses (NTNU=42; UQ = 20). Outcomes of per 
protocol analyses are only presented in-text when statistical significance of the intervention 
effect differed between per protocol and intention-to-treat analyses. 
Obese and Healthy-Weight Children 
A summary of baseline characteristics and comparison of ( CV) outcomes for obese 
and healthy-weight children are presented in Supplemental Table 1. There were no 
differences in age, sex or Tanner stage of puberty between the populations (obese: 12.0 (2.3 
years), 53 [53.5%] female, Tanner stage 3 [2–4]; healthy-weight: 11.5 (2.4 years), 50 [51.0%] 
female, Tanner stage 2 [1–3]). Obese children showed lower LV and RV systolic and 
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diastolic function at rest when compared to healthy-weight children including significantly 
lower resting LV peak systolic tissue velocity (-1.7cm/s, 95% CI -2.0 to -1.3cm/s, P<0.001).  
Intervention Effects in Obese Children 
There were no differences in age, sex and Tanner stage of puberty between 
intervention groups (HIIT: 12.4 (1.9 years), 17 [51.5%] female, Tanner stage 3 [2– 4]; MICT: 
11.9 (2.4 years), 17 [53.1%] female, Tanner stage 2 [1–4]; nutrition: 11.8 (2.4 years), 19 
[55.9%] female, Tanner stage 3 [1–4]). Exercise training data are presented in Table 1. There 
were no adverse events over the study duration.  
A summary of CV outcomes at baseline and post intervention is presented for each 
group (Table 2 and Supplemental Table 2). Table 3 and Supplemental Table 3 present 
the estimated between-group intervention effects for all outcomes. Linear mixed models were 
also fitted to include an interaction effect between center and intervention. However, this 
interaction effect was only significant for five outcome variables. In light of multiple testing, 
and for ease of interpretation and generalizability of findings, the results presented are for 
models without this interaction effect, but were adjusted for center by a main effect. Model 
parameters were also adjusted for age and sex effects on outcomes of interest (Table 3).  
Resting Cardiac Function  
Twelve weeks of HIIT and MICT significantly improved systolic cardiac function (LV S’) at 
rest compared to the nutrition only group (1.0cm/s, 95% CI 0.5 to 1.6cm/s, P<0.001; 0.7cm/s, 
95% CI 0.2 to 1.3cm/s, P=0.010, respectively) (Figure 3 A & C). There were no significant 
differences between the HIIT and MICT interventions for changes in LV S’. Intervention 
effects were noted for global cardiac function with HIIT demonstrating superior increases in 
ejection fraction ( EF; 4.0 percent point (pp), 95% CI 0.1 to 8.0pp, P=0.045) and stroke 
volume index (6.8mL/m
2
, 95% CI 2.7 to 10.9mL/m
2
,
 
P=0.001) when compared to MICT. The 
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benefits of HIIT and MICT compared to the nutrition only intervention appeared to extend to 
resting RV function with increases noted in e’, GLS and SR (Table 3).  
In addition, HIIT improved RV e’ (2.1cm/s, 95% CI 0.5 to 3.6cm/s, P=0.009) and 
GLS (-3.0pp, -0.5 to -5.5pp, P=0.020) compared to twelve weeks of MICT.  
Peak Exercise and Recovery Cardiac Function 
Pairwise comparisons for LV S’, V̇maxLVOT, and stroke volume index at peak 
exercise revealed that while there were no differences between HIIT and MICT interventions, 
the exercise interventions were superior to nutrition advice only for eliciting improvements in 
these outcomes (Table 3, Figure 3 B & D). Importantly, the estimated mean differences 
between the exercise and nutrition groups for peak exercising LV S’ were clinically 
significant 
11
. The exercise interventions increased recovery systolic cardiac function (LV S’) 
compared to the nutrition only intervention while the HIIT group exhibited greater 
improvements in recovery diastolic cardiac function (LV e’) compared to the nutrition only 
group (Supplemental Table 3).  
Vascular Function and Cardiorespiratory Fitness 
 Vascular function assessed through brachial FMD improved in the nutrition only 
group compared to the HIIT (4.2pp, 95% CI 1.2 to 7.2pp, P=0.005) and MICT (3.3pp, 0.3 to 
6.3pp, P=0.033) interventions. Given this is in stark contrast with previous research, we 
recognise it may be a spurious finding resulting from multiple testing. Per protocol analysis 
revealed a clinically significant difference in CRF between the HIIT and MICT groups 
(3.6mL/kg/min, 95% CI 1.1 to 6.0mL/kg/min, P=0.004).  
DISCUSSION 
Pediatric obesity leads to detrimental CV changes and impacts future CVD risk and 
premature mortality 
1,2
. To the best of our knowledge, this is the first randomised controlled 
trial to compare the efficacy of HIIT and MICT on cardiac function in obese children. Our 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 13 
novel findings show that twelve weeks of HIIT and MICT were superior to nutrition advice 
only for improving resting systolic cardiac function (LV S’) in pediatric obesity. Importantly, 
both exercise interventions normalised LV S’ in obese children compared to their healthy 
weight counterparts (post HIIT versus healthy-weight, P=0.38; post MICT versus healthy-
weight, P=0.19). The complex mechanics of the heart are best represented by several 
outcome measures and HIIT conferred significantly greater improvements in global cardiac 
function, and RV myocardial contractility compared to MICT and nutrition advice only. 
Secondly, results suggested that the favourable effects of the exercise training interventions 
compared to the nutrition intervention extended to peak exercising cardiac function in this 
population. Together, these findings highlight the importance of regular exercise, potentially 
of a higher intensity, to ameliorate cardiac health in children with obesity. 
 Although we hypothesised that HIIT would be more effective than MICT for 
improving the primary outcome, resting systolic cardiac function (LV S’), both exercise 
interventions were equally efficacious and superior to the nutrition only intervention. Still, 
our findings suggest that HIIT was a more potent stimulus for improving global cardiac 
function and myocardial contractility than MICT. This is consistent with evidence from 
adults with chronic disease 
18,19,30-32
 and animal models 
33-35
. Wisloff et al. (2007) showed 
that twelve weeks of HIIT was superior to MICT and standard care for improving EF (10pp 
or 35% increase, P<0.020) in patients with stable post infarction heart failure 
18
. While the 
increase in EF following HIIT in our study was smaller than previously noted in clinical adult 
populations (4.3pp or 7.5% increase, P=0.004), we note that HIIT normalised EF compared 
to the healthy-weight controls (post HIIT EF 61.8% versus healthy weight EF 62.5%, 
P=0.58). This outcome is complemented by a significant increase in stroke volume and stroke 
volume index noted in our study and previous work 
5,18,19,32
. Importantly, improvements in 
tissue Doppler velocities bear prognostic significance. Westholm et al. (2013) illustrated that 
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a 0.9cm/s reduction in systolic cardiac function (LV S’) was associated with all-cause 
mortality, myocardial infarction or rehospitalisation for heart failure in acute coronary 
syndrome patients 
11
. While this observation may appear irrelevant to children with obesity, 
this population exhibits markedly diminished cardiac function and significant alterations in 
cardiac structure, when compared to healthy-weight counterparts. Given the reasonable 
likelihood that obese children will become obese adults 
36
, our data support a role for exercise 
interventions to ameliorate cardiac function early in childhood and adolescence to prevent 
CVD later in adult life.  
Our study indicates that significant improvements in RV systolic (GLS) and diastolic 
(e’) function can be attained following twelve weeks of HIIT compared to MICT and 
nutrition only. Pediatric obesity is associated with subclinical premature reductions in RV 
systolic and diastolic function as demonstrated by this study and earlier findings 
8
. These 
alterations may be resolved through a diet-induced weight reduction in obese children 
37
. To 
our knowledge, this is the first multidisciplinary lifestyle intervention that incorporates HIIT, 
to potentially restore systolic and diastolic RV function in children with obesity.  
 While we hypothesised that HIIT would be the most beneficial intervention for 
eliciting increases in peak exercise cardiac function, our findings showed no differences 
between the exercise interventions (HIIT and MICT). As expected, the HIIT and MICT 
groups exhibited superior systolic function during peak exercise following the interventions 
(LV S’, peak ejection velocity in the LV outflow tract, indexed-stroke volume) in comparison 
to the nutrition only group. To our knowledge, pilot work by our group is the only other study 
to report peak exercise echocardiography outcomes showing significant increases in S’ and 
peak ejection velocity following a HIIT intervention 
5
. The extent to which peak exercising 
cardiac function improves as a consequence of short-term exercise training is currently 
unclear and may be partially attributed to the accuracy of assessment. Further research is 
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warranted in pediatric and adult populations alike to contribute to the paucity of evidence 
exploring this outcome.   
This is the first study to illustrate the efficacy of HIIT and MICT on cardiac function in 
children with obesity to date. Future studies should attempt to replicate these results in larger 
and more diverse cohorts. We acknowledge that the vascular function results are limited 
methodological discrepancies between the study centres which may explain why our finding 
is contrary to the results of a recent meta-analysis in children with obesity 
38
. Furthermore, 
peak oxygen uptake and exercising cardiac function were not assessed simultaneously; peak 
heart rate was significantly lower (30 beats/min) during the exercise echocardiography 
assessments than during the CRF assessment to permit acquisition of clear images. This 
limits our ability to make precise mechanistic conclusions. It also unclear whether the 
superior effect of HIIT on global cardiac function and CRF in our study, is due to increased 
intensity or the presence of intermittent efforts when compared to MICT 
39
. Recent evidence 
suggests that moderate intensity interval training may provide similar benefits with regards to 
metabolic health in obese adolescent females 
40
, and fat oxidation in obese men 
41
. While this 
type of training may be particularly relevant in high-risk clinical populations, current 
evidence regarding the benefits of moderate intensity interval training, particularly on CV 
function, remains limited. Finally, it is important to consider the retention and adherence of 
participants in the exercise program. While we hypothesised that children would express 
increased enjoyment during HIIT as the stop-start nature of this exercise prescription closely 
reflected childhood play, we noted marginally greater attrition in the HIIT group (30%) 
compared to the MICT (25%) and nutrition advice only (21%) interventions, with 25% of 
children dropping out of the overall intervention. To date, program completion is the only 
available outcome assessing ‘enjoyment’ or acceptability of HIIT and MICT interventions in 
pediatric obesity. It is pertinent that future research assesses enjoyment using validated scales 
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or questionnaire as without enjoyment, individuals are unlikely to adhere to exercise, 
particularly in an unsupervised setting. Furthermore, although a ‘lack of time, interest and 
motivation’ were the most commonly stated reasons for attrition, these opinions likely reflect 
the entire family, as children were strongly dependent on their parents particularly for 
transportation to and from the study centres. In light of this, we believe that family-based 
interventions may be more successful with regards to retention and adherence however 
current evidence remains limited. 
In conclusion, twelve weeks of HIIT and MICT improved resting systolic cardiac 
function (LV S’) in children with obesity to similar levels seen in healthy-weight children. 
Moreover, it appears that HIIT ameliorated other outcomes of resting and peak exercise 
cardiac function in children with obesity. These findings advocate for structured exercise 
programs, including HIIT to improve CV health outcomes in pediatric obesity.   
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 17 
ACKNOWLEDGEMENTS 
The authors thank the study dietitian for holding nutrition consultations with participants and 
their families at The University of Queensland, and echocardiographers at The Wesley 
Hospital for their technical expertise. Cardiorespiratory fitness testing and exercise sessions 
were conducted at the core facility NeXt Move, Norwegian University of Science and 
Technology (NTNU). 
 
 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 18 
REFERENCES 
1. Reilly JJ, Kelly J. Long-term impact of overweight and obesity in childhood and 
adolescence on morbidity and premature mortality in adulthood: systematic review. Int 
J Obes (Lond). 2010;35(7):891-898. doi:10.1038/ijo.2010.222. 
2. Gunnell DJ, Frankel SJ, Nanchahal K, Peters TJ, Davey Smith G. Childhood obesity 
and adult cardiovascular mortality: a 57-y follow-up study based on the Boyd Orr 
cohort. Am J Clin Nutr. 1998;67(6):1111-1118. 
3. Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and 
mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 
1922 to 1935. N Engl J Med. 1992;327(19):1350-1355. 
doi:10.1056/NEJM199211053271904. 
4. Mangner N, Scheuermann K, Winzer E, et al. Childhood obesity: impact on cardiac 
geometry and function. JACC Cardiovasc Imaging. 2014;7(12):1198-1205. 
doi:10.1016/j.jcmg.2014.08.006. 
5. Ingul CB, Tjonna AE, Stolen TO, Stoylen A, Wisloff U. Impaired cardiac function 
among obese adolescents: effect of aerobic interval training. Arch Pediatr Adolesc 
Med. 2010;164(9):852-859. doi:10.1001/archpediatrics.2010.158. 
6. Singh GK, Vitola BE, Holland MR, et al. Alterations in ventricular structure and 
function in obese adolescents with nonalcoholic fatty liver disease. J Pediatr. 
2013;162(6):1160–8–1168.e1. doi:10.1016/j.jpeds.2012.11.024. 
7. Labombarda F, Zangl E, Dugue AE, et al. Alterations of left ventricular myocardial 
strain in obese children. Eur Heart J Cardiovasc Imaging. 2013;14(7):668-676. 
doi:10.1093/ehjci/jes238. 
8. Barbosa JAA, Mota CCC, Simões E Silva AC, Nunes MDCP, Barbosa MM. 
Assessing pre-clinical ventricular dysfunction in obese children and adolescents: the 
value of speckle tracking imaging. Eur Heart J Cardiovasc Imaging. 2013;14(9):882-
889. doi:10.1093/ehjci/jes294. 
9. Obert P, Gueugnon C, Nottin S, et al. Impact of diet and exercise training-induced 
weight loss on myocardial mechanics in severely obese adolescents. Obesity. 
2013;21(10):2091-2098. doi:10.1002/oby.20495. 
10. Zachariah JP, Ingul CB, Marx GR. Linking pediatric obesity to subclinical alterations 
in cardiac structure and function. JACC Cardiovasc Imaging. 2014;7(12):1206-1208. 
doi:10.1016/j.jcmg.2014.09.006. 
11. Westholm C, Johnson J, Sahlen A, Winter R, Jernberg T. Peak systolic velocity using 
color-coded tissue Doppler imaging, a strong and independent predictor of outcome in 
acute coronary syndrome patients. Cardiovasc Ultrasound. 2013;11(9):1-8. 
doi:10.1186/1476-7120-11-9. 
12. Watts K, Beye P, Siafarikas A, et al. Effects of exercise training on vascular function 
in obese children. J Pediatr. 2004;144(5):620-625. doi:10.1016/j.jpeds.2004.02.027. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 19 
13. Farpour-Lambert NJ, Aggoun Y, Marchand LM, Martin XE, Herrmann FR, Beghetti 
M. Physical activity reduces systemic blood pressure and improves early markers of 
atherosclerosis in pre-pubertal obese children. J Am Coll Cardiol. 2009;54(25):2396-
2406. doi:10.1016/j.jacc.2009.08.030. 
14. Meyer AA, Kundt G, Lenschow U, Schuff-Werner P, Kienast W. Improvement of 
early vascular changes and cardiovascular risk factors in obese children after a six-
month exercise program. J Am Coll Cardiol. 2006;48(9):1865-1870. 
doi:10.1016/j.jacc.2006.07.035. 
15. Naylor LH, Watts K, Sharpe JA, et al. Resistance training and diastolic myocardial 
tissue velocities in obese children. Med Sci Sports Exerc. 2008;40(12):2027-2032. 
doi:10.1249/MSS.0b013e318182a9e0. 
16. Tremblay MS, Gray CE, Akinroye K, et al. Physical activity of children: a global 
matrix of grades comparing 15 countries. J Phys Act Health. 2014;11 Suppl 1:S113-
S125. doi:10.1123/jpah.2014-0177. 
17. Weston KS, Wisloff U, Coombes JS. High-intensity interval training in patients with 
lifestyle-induced cardiometabolic disease: a systematic review and meta-analysis. Br J 
Sports Med. 2014;48(16):1227-1234. doi:10.1136/bjsports-2013-092576. 
18. Wisloff U, Stoylen A, Loennechen JP, et al. Superior Cardiovascular Effect of Aerobic 
Interval Training Versus Moderate Continuous Training in Heart Failure Patients: A 
Randomized Study. Circulation. 2007;115(24):3086-3094. 
doi:10.1161/CIRCULATIONAHA.106.675041. 
19. Mølmen-Hansen HE, Stolen T, Tjonna AE, et al. Aerobic interval training reduces 
blood pressure and improves myocardial function in hypertensive patients. Eur J Prev 
Cardiol. 2012;19(2):151-160. doi:10.1177/1741826711400512. 
20. Cassidy S, Thoma C, Hallsworth K, et al. High intensity intermittent exercise 
improves cardiac structure and function and reduces liver fat in patients with type 2 
diabetes: a randomised controlled trial. Diabetologia. 2016;59(1):56-66. 
doi:10.1007/s00125-015-3741-2. 
21. Ramos JS, Dalleck LC, Tjonna AE, Beetham KS, Coombes JS. The impact of high-
intensity interval training versus moderate-intensity continuous training on vascular 
function: a systematic review and meta-analysis. Sports Med. 2015;45(5):679-692. 
doi:10.1007/s40279-015-0321-z. 
22. Batacan RB Jr., Duncan MJ, Dalbo VJ, Tucker PS, Fenning AS. Effects of high-
intensity interval training on cardiometabolic health: a systematic review and meta-
analysis of intervention studies. Br J Sports Med. October 2016:bjsports–2015–
095841–13. doi:10.1136/bjsports-2015-095841. 
23. García-Hermoso A, Cerrillo-Urbina AJ, Herrera-Valenzuela T, Cristi-Montero C, 
Saavedra JM, Martínez-Vizcaíno V. Is high-intensity interval training more effective 
on improving cardiometabolic risk and aerobic capacity than other forms of exercise in 
overweight and obese youth? A meta-analysis. Obes Rev. 2016;17(6):531-540. 
doi:10.1111/obr.12395. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 20 
24. Cole T, Bellizzi M, Flegal K, Dietz W. Establishing a standard definition for child 
overweight and obesity worldwide: international survey. BMJ. 2000;320:1-6. 
25. Cole TJ, Lobstein T. Extended international (IOTF) body mass index cut-offs for 
thinness, overweight and obesity. Pediatr Obes. 2012;7(4):284-294. 
doi:10.1111/j.2047-6310.2012.00064.x. 
26. Dias KA, Coombes JS, Green DJ, et al. Effects of exercise intensity and nutrition 
advice on myocardial function in obese children and adolescents: a multicentre 
randomised controlled trial study protocol. BMJ Open. 2016;6(4):e010929. 
doi:10.1136/bmjopen-2015-010929. 
27. Thijssen DHJ, Black MA, Pyke KE, et al. Assessment of flow-mediated dilation in 
humans: a methodological and physiological guideline. Am J Physiol Heart Circ 
Physiol. 2011;300(1):H2-H12. doi:10.1152/ajpheart.00471.2010. 
28. Helsedirektoratet. Anbefalinger Om Kosthold, Ernæring Og Fysisk Aktivitet. 2014:1-
28. 
29. National Health and Medical Research Council. Australian Dietary Guidelines. 
Canberra; 2013:1-226. 
30. Hollekim-Strand SM, Høydahl SF, Follestad T, et al. Exercise Training Normalizes 
Timing of Left Ventricular Untwist Rate, but Not Peak Untwist Rate, in Individuals 
with Type 2 Diabetes and Diastolic Dysfunction: A Pilot Study. J Am Soc 
Echocardiogr. 2016;29(5):421-430.e422. doi:10.1016/j.echo.2016.01.005. 
31. Hollekim-Strand SM, Malmo V, Follestad T, Wisloff U, Ingul CB. Fast food increases 
postprandial cardiac workload in type 2 diabetes independent of pre-exercise: A pilot 
study. Nutr J. 2015;14(79):2-11. doi:10.1186/s12937-015-0069-1. 
32. Brønstad E, Tjonna AE, Rognmo Ø, et al. Aerobic Exercise Training Improves Right-
and Left Ventricular Systolic Function in Patients with COPD. COPD: Journal of 
Chronic Obstructive Pulmonary Disease. 2013;10(3):300-306. 
33. Kemi OJ, Haram PM, Loennechen JP, et al. Moderate vs. high exercise intensity: 
differential effects on aerobic fitness, cardiomyocyte contractility, and endothelial 
function. Cardiovasc Res. 2005;67(1):161-172. doi:10.1016/j.cardiores.2005.03.010. 
34. Johnsen AB, Høydal M, Røsbjørgen R, Stolen T, Wisloff U. Aerobic Interval Training 
Partly Reverse Contractile Dysfunction and Impaired Ca2+ Handling in Atrial 
Myocytes from Rats with Post Infarction Heart Failure. de Windt LJ, ed. PLoS ONE. 
2013;8(6):e66288. doi:10.1371/journal.pone.0066288.g004. 
35. Stølen TO, Høydal MA, Kemi OJ, et al. Interval training normalizes cardiomyocyte 
function, diastolic Ca2+ control, and SR Ca2+ release synchronicity in a mouse model 
of diabetic cardiomyopathy. Circ Res. 2009;105(6):527-536. 
doi:10.1161/CIRCRESAHA.109.199810. 
36. Vanhala M, Vanhala P, Kumpusalo E, Halonen P, Takala J. Relation between obesity 
from childhood to adulthood and the metabolic syndrome: population based study. 
BMJ. 1998;317(7154):319. 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 21 
37. Zeybek C, Aktuglu-Zeybek C, Onal H, Altay S, Erdem A, Celebi A. Right Ventricular 
Subclinical Diastolic Dysfunction in Obese Children: The Effect of Weight Reduction 
with a Low-Carbohydrate Diet. Pediatr Cardiol. 2009;30(7):946-953. 
doi:10.1007/s00246-009-9472-8. 
38. Dias KA, Green DJ, Ingul CB, Pavey TG, Coombes JS. Exercise and Vascular 
Function in Child Obesity: A Meta-Analysis. PEDIATRICS. 2015;136(3):e648-e659. 
doi:10.1542/peds.2015-0616. 
39. Jiménez-Pavón D, Lavie CJ. High-intensity intermittent training versus moderate-
intensity intermittent training: is it a matter of intensity or intermittent efforts? Br J 
Sports Med. January 2017. doi:10.1136/bjsports-2016-097015. 
40. Racil G, Coquart JB, Elmontassar W, et al. Greater effects of high- compared with 
moderate-intensity interval training on cardio-metabolic variables, blood leptin 
concentration and ratings of perceived exertion in obese adolescent females. Biol 
Sport. 2016;33(2):145-152. doi:10.5604/20831862.1198633. 
41. Alkahtani SA, King NA, Hills AP, Byrne NM. Effect of interval training intensity on 
fat oxidation, blood lactate and the rate of perceived exertion in obese men. 
Springerplus. 2013;2(1):532. doi:10.1186/2193-1801-2-532. 
  
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 22 
FIGURE LEGENDS 
Figure 1. Exercise training protocols. Schematic representation detailing time and intensity of 
A. HIIT and B. MICT sessions  
Figure 2. CONSORT flow chart. Illustration detailing the number of patients enrolled, 
randomised and assessed at each time point.  
Figure 3. Effect of the interventions on peak systolic tissue velocity at rest (A, C) and peak 
systolic tissue velocity at peak exercise (B, D). A. and B. illustrate the mean (horizontal bar) 
and individual (circles) change scores for each intervention group while C. and D. show 
between-group comparisons (estimated mean difference and 95% confidence intervals). * 
Significant intervention effect (P = 0.001 [A] and P = 0.040 [B]). 
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FIGURES 
 
Figure 1. Exercise training protocols. Schematic representation detailing time and intensity of 
A. HIIT and B. MICT sessions  
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Figure 2. CONSORT flow chart. Illustration detailing the number of patients enrolled, 
randomised and assessed at each time point.  
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Figure 3. Effect of the interventions on peak systolic tissue velocity at rest (A, C) and peak 
systolic tissue velocity at peak exercise (B, D). A. and B. illustrate the mean (horizontal bar) 
and individual (circles) change scores for each intervention group while C. and D. show 
between-group comparisons (estimated mean difference and 95% confidence intervals).  
* Significant intervention effect (P = 0.001 [A] and P = 0.040 [B]). 
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Table 1. Exercise training data for the two training arms 
Average/session month 1 2 3 Average 
HIIT (n = 17)     
Average HR (bpm) 174 (13)  175 (13)  174 (10)  173 (10)  
Intensity (HRmax%) 90 (4)  91 (4)  91 (3)  91 (3)  
Duration (min) 40 (0)  40 (0)  40 (0)  40 (0)  
Attendance (%) 74 (23) 68 (30) 63 (34) 68 (27) 
MICT (n = 24)     
Average HR (bpm) 137 (9) 136 (9) 138 (11) 132 (9) 
Intensity (HRmax%) 72 (5) 72 (5) 73 (6) 72 (5) 
Duration (min) 44 (0) 44 (0) 44 (0) 44 (0) 
Attendance (%) 66 (25) 60 (31) 41 (35) 56 (27) 
 
HIIT, high intensity interval training; MICT, moderate intensity interval training; HR, heart 
rate. Mean (SD) shown for participants who completed the intervention (per protocol 
analysis) 
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Table 2. Baseline and post intervention data for cardiac function during rest and peak exercise  
 HIIT MICT Nutrition 
 
Baseline Post Baseline Post Baseline Post 
Variable n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) n Mean (SD) 
LV function at rest                         
S' (cm/s) 33 8.6 (1.5) 25 10.1 (1.6) 32 8.8 (1.3) 26 9.8 (1.7) 34 8.4 (0.9) 24 8.8 (1.1) 
e' (cm/s) 33 14.9 (2.2) 25 17.1 (2.4) 32 15.3 (2.2) 26 16.2 (2.3) 34 15.0 (2.3) 24 15.4 (2.7) 
A' (cm/s) 32 6.9 (1.5) 25 7.3 (1.3) 32 7.0 (1.3) 26 7.2 (1.4) 34 7.1 (0.8) 24 7.1 (0.9) 
GLS (%) 33 -17.3 (3.0) 23 -18.9 (2.1) 32 -17.3 (3.0) 26 -18.1 (2.7) 33 -16.7 (3.0) 22 -16.8 (2.6) 
SR (s
-1
) 33 -0.9 (0.2) 23 -1.0 (0.1) 32 -0.9 (0.1) 26 -1.0 (0.1) 33 -0.9 (0.2) 21 -0.9 (0.1) 
LVEDVi (mL/m
2
) 33 64.6 (18.4) 25 74.4 (17.9) 32 68.2 (17.8) 26 68.4 (15.5) 34 61.2 (20.9) 27 64.3 (20.4) 
LVESVi (mL/m
2
) 33 27.6 (10.7) 25 30.4 (10.9) 32 27.1 (7.1) 26 28.8 (7.4) 34 27.0 (9.1)_ 27 28.5 (8.9) 
EF (%) 33 57.5 (8.7) 25 61.8 (6.8) 32 58.4 (8.0) 26 58.3 (7.0) 34 55.0 (7.7) 27 54.4 (6.3) 
SVi (mL/m
2
) 32 40.2 (8.6) 25 46.3 (9.6) 32 40.5 (9.2) 25 39.0 (8.5) 34 39.0 (9.6) 24 38.6 (11.0) 
CI (L/min/m
2
) 32 3.0 (0.5) 22 2.9 (0.6) 32 3.2 (0.8) 25 2.9 (0.7) 34 3.0 (0.7) 24 2.8 (0.8) 
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RV function at rest 
            
S' (cm/s) 32 13.1 (2.0) 24 14.9 (2.3) 32 13.5 (2.2) 23 14.3 (2.2) 34 12.7 (2.1) 24 13.5 (2.5) 
e' (cm/s) 32 15.1 (2.9) 24 17.1 (3.0) 32 14.9 (2.8) 23 15.0 (3.2) 34 14.5 (2.9) 24 14.6 (2.2) 
A' (cm/s) 32 9.2 (2.5) 24 9.8 (2.5) 32 8.6 (2.5) 23 9.3 (2.6) 34 10.0 (3.2) 24 9.3 (2.3) 
GLS (%) 31 -20.4 (4.6) 21 -25.6 (5.2) 30 -19.6 (5.9) 23 -21.4 (6.6) 28 -21.1 (3.8) 21 -22.0 (5.5) 
SR (s
-1
) 31 -1.2 (0.3) 23 -1.5 (0.5) 30 -1.2 (0.5) 23 -1.5 (0.6) 31 -1.2 (0.3) 21 -1.2 (0.6) 
LV function during peak exercise                     
S' (cm/s) 32 13.4 (2.0) 25 14.7 (1.3) 31 13.0 (2.3) 26 14.2 (1.5) 33 12.8 (2.3) 25 13.5 (1.5) 
e' (cm/s) 32 13.9 (1.7) 25 14.1 (1.6) 31 13.4 (2.3) 26 13.9 (1.6) 33 13.7 (2.2) 25 13.6 (2.0) 
V̇maxLVOT (m/s) 30 1.5 (0.3) 21 1.7 (0.2) 32 1.5 (0.4) 24 1.6 (0.3) 32 1.5 (0.2) 24 1.4 (0.3) 
SVi (mL/m
2
) 30 35.2 (9.0) 20 44.2 (9.7) 32 40.7 (19.0) 23 40.1 (10.3) 32 40.4 (9.4) 23 38.0 (11.2) 
CI (L/min/m
2
) 30 5.8 (1.3) 20 7.3 (1.8) 32 6.4 (2.7) 23 6.6 (2.1) 32 6.4 (1.9) 23 6.2 (1.6) 
LV function during recovery          
S’ (cm/s) 32 6.8 (1.3) 23 9.3 (2.1) 31 7.5 (1.5) 26 9.3 (1.9) 32 7.2 (1.3) 25 8.0 (1.0) 
e’ (cm/s) 32 7.5 (1.4) 23 9.6 (1.8) 31 7.4 (1.6) 26 8.8 (1.7) 32 7.9 (1.8) 25 8.3 (1.8) 
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A’ (cm/s) 32 4.3 (1.3) 23 4.7 (1.8) 31 4.8 (1.8) 26 5.3 (2.3) 32 5.0 (2.0) 25 4.9 (1.8) 
Vascular function and cardiorespiratory fitness          
Baseline BA diameter 
(cm) 
19 3.1 (0.5) 14 3.2 (0.3) 11 3.4 (0.4) 14 3.3 (0.4) 17 3.2 (0.3) 11 3.2 (0.4) 
FMD (%) 19 6.2 (4.3) 14 4.1 (2.9) 11 7.4 (3.8) 14 5.1 (4.6) 17 6.7 (4.4) 11 7.6 (3.9) 
V̇O2peak (mL/kg/min) 33 31.2 (5.9) 22 36.6 (7.4) 29 32.2 (5.2) 25 33.6 (6.3) 31 31.6 (5.5) 26 32.2 (5.9) 
V̇O2peak 
(mL/kg
FFM
/min) 
25 58.8 (8.9) 17 64.5 (8.3) 25 59.9 (9.2) 22 59.7 (12.0) 26 59.8 (8.0) 16 57.6 (8.8) 
 
HIIT, high intensity interval training; MICT, moderate intensity continuous training; S’, peak systolic tissue velocity; e’, peak early diastolic tissue 
velocity; A’, peak late diastolic tissue velocity; GLS, global longitudinal strain; SR, strain rate; LVEDVi, left ventricular end diastolic volume index; 
LVESVi, left ventricular end systolic volume index; EF, ejection fraction; SVi, stroke volume index; CI, cardiac index; V̇maxLVOT, maximal velocity 
in left ventricular outflow tract; FMD, flow mediated dilation; BA, brachial artery; V̇O2peak, peak oxygen consumption; FFM, fat free mass 
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Table 3. Between group estimated mean differences for cardiac function, vascular function and cardiorespiratory fitness during rest, peak 
exercise and recovery 
 
HIIT versus MICT HIIT versus NUTRITION MICT versus NUTRITION Int Age Sex 
  
95% CI 
  
95% CI 
  
95% CI 
    Variable EMD Low Up P EMD Low Up P EMD Low Up P P P P 
LV function at rest 
               
S' (cm/s) 0.3 -0.2 0.9 0.24 1.0 0.5 1.6 <0.001 0.7 0.2 1.3 0.010 0.001 0.004 0.28 
e' (cm/s) 0.7 -0.4 1.8 0.20 1.5 0.4 2.7 0.007 0.8 -0.3 1.9 0.15 0.026 0.51 0.19 
A' (cm/s) 0.3 -0.2 0.9 0.26 0.3 -0.3 0.9 0.29 0.0 -0.6 0.5 0.96 0.45 0.022 0.57 
GLS (%) -1.0 -2.1 0.0 0.053 -1.7 -2.8 -0.6 0.002 -0.7 -1.8 0.4 0.21 0.009 0.016 0.053 
SR (s
-1
) -0.0 -0.1 0.0 0.36 -0.1 -0.2 -0.0 0.004 -0.1 -0.1 0.0 0.040 0.018 0.016 0.15 
LVEDVi (mL/m
2
) 4.8 -2.1 11.6 0.18 5.5 -1.4 12.3 0.12 0.7 -5.9 7.3 0.84 0.24 0.42 0.87 
LVESVi (mL/m
2
) 0.7 -3.8 5.2 0.77 1.0 -3.5 5.5 0.66 0.3 -4.0 4.6 0.89 0.91 0.68 0.25 
EF (%) 4.0 0.1 8.0 0.045 6.2 2.3 10.1 0.002 2.2 -1.7 6.0 0.28 0.007 0.53 0.22 
SVi (mL/m
2
) 6.8 2.7 10.9 0.001 6.9 2.7 11.1 0.001 0.1 -3.9 4.0 0.96 0.001 0.44 0.66 
CI (L/min/m
2
) 0.0 -0.3 0.4 0.91 0.1 -0.3 0.4 0.74 0.0 -0.3 0.4 0.81 0.94 0.032 0.77 
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RV function at rest 
               
S’ (cm/s) 0.7 -0.4 1.8 0.20 1.2 0.1 2.3 0.032 0.5 -0.6 1.6 0.40 0.093 0.36 0.17 
e’ (cm/s) 2.1 0.5 3.6 0.009 2.2 0.7 3.8 0.005 0.2 -1.4 1.7 0.83 0.008 0.39 0.083 
A’ (cm/s) 1.1 -0.3 2.4 0.12 1.1 -0.3 2.4 0.12 0.0 -1.4 1.4 0.99 0.20 0.59 0.10 
GLS (%) -3.0 -5.5 -0.5 0.020 -4.3 -6.9 -1.7 0.001 -1.3 -3.8 1.2 0.32 0.005 0.098 0.43 
SR (s
-1
) -0.1 -0.3 0.1 0.46 -0.4 -0.6 -0.2 0.001 -0.3 -0.5 -0.1 0.005 0.002 0.79 0.27 
LV function during peak exercise 
             
S' (cm/s) 0.1 -0.7 1.0 0.77 1.0 0.2 1.8 0.020 0.9 0.0 1.7 0.039 0.040 <0.001 0.19 
e' (cm/s) 0.0 -0.9 0.9 0.95 0.3 -0.6 1.3 0.47 0.4 -0.6 1.3 0.43 0.68 0.004 0.15 
V̇maxLVOT (m/s) 0.1 0.0 0.3 0.14 0.3 0.1 0.5 <0.001 0.2 0.0 0.3 0.029 0.002 0.020 0.12 
SVi (mL/m
2
) 
*
 0.1 -0.1 0.3 0.21 0.3 0.1 0.4 0.003 0.1 0.0 0.3 0.066 0.023  0.77 0.67 
CI (L/min/m
2
)
 *
 0.0 -0.1 0.1 0.82 0.0 -0.1 0.2 0.52 0.0 -0.1 0.2 0.67 0.81 0.071 0.66 
LV function during recovery            
S’ (cm/s) 0.1 -0.7 0.9 0.76 1.4 0.6 2.2 0.001 1.2 0.5 2.0 0.002 0.001 <0.001 0.93 
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e’ (cm/s) 0.6 -0.3 1.5 0.17 1.2 0.3 2.1 0.010 0.6 -0.3 1.4 0.21 0.036 0.89 0.71 
A’ (cm/s) * -0.1 -0.3 0.1 0.4 0.0 -0.2 0.2 0.97 0.1 -0.1 0.3 0.32 0.57 0.26 0.80 
Vascular function and cardiorespiratory fitness            
Baseline BA diameter 
(cm) 
-0.1 -0.3 0.2 0.67 0.0 -0.2 0.2 0.92 0.0 -0.2 0.3 0.77 0.90 <0.001 0.079 
FMD (%) -0.9 -3.7 1.9 0.53 -4.2 -7.2 -1.2 0.005 -3.3 -6.3 -0.3 0.033 0.025 0.88 0.59 
V̇O2peak (mL/kg/min) 2.3 -0.1 4.6 0.062 4.1 1.7 6.4 0.001 1.8 -0.5 4.1 0.12 0.003 0.66 0.019 
V̇O2peak 
(mL/kg
FFM
/min) 
4.9 0.2 9.6 0.042 8.1 3.0 13.2 0.002 3.2 -1.6 8.0 0.19 0.007 0.85 0.012 
 
Data are based on intention to treat analyses. HIIT, high intensity interval training; MICT, moderate intensity continuous training; Int, intervention 
effect; EMD, estimated mean difference; S’, peak systolic tissue velocity; e’, peak early diastolic tissue velocity; A’, peak late diastolic tissue velocity; 
GLS, global longitudinal strain; SR, strain rate; LVEDVi, left ventricular end diastolic volume index; LVESVi, left ventricular end systolic volume 
index; EF, ejection fraction; SVi, stroke volume index; CI, cardiac index; V̇maxLVOT; maximal velocity in left ventricular outflow tract; BA, brachial 
artery; FMD, flow mediated dilation; V̇O2peak, peak oxygen consumption; FFM, fat free mass 
*
 Model estimates presented in natural logarithmic (ln) scale. 
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